Literature DB >> 3079950

Decision analysis in evaluation of hypergastrinemia.

E Spindel, R F Harty, J R Leibach, J E McGuigan.   

Abstract

Hypergastrinemia and gastric acid hypersecretion are the principal laboratory features of Zollinger-Ellison syndrome. Decision and cost-effectiveness analyses were employed in the present study to compare and contrast the diagnostic strategies of initial gastric analysis followed by secretin infusion test versus secretin infusion test alone in the evaluation of hypergastrinemia in patients suspected of having gastrinoma. The results of this study showed that 59 percent of patients with elevated serum gastrin values were either hypochlorhydric or achlorhydric. Application of decision analysis to either diagnostic strategy demonstrated that gastric analysis followed by secretin infusion test, if indicated, was superior in expected value than secretin infusion test alone. Likewise, in this group of patients, performance of gastric analysis in the outpatient setting prior to secretin infusion testing was financially more advantageous than performance of secretin infusion testing alone. These results also demonstrate the importance of performing gastric analysis prior to anticipated hospitalization for evaluation of suspected gastrinoma. Such testing would obviate unnecessary hospitalization and medical costs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079950     DOI: 10.1016/0002-9343(86)90042-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.

Authors:  M J Collen; M J Sheridan
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

2.  Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome.

Authors:  M J Collen; R T Jensen
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

3.  Validation of a new endoscopic technique to assess acid output in Zollinger-Ellison syndrome.

Authors:  David S Oh; Hank S Wang; Gordon V Ohning; Joseph R Pisegna
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11-13       Impact factor: 11.382

Review 4.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.